About Sentiss Pharma Private Limited
Data last updated: 09 January 2026
Sentiss Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 13 January 1994, the company has been in operation for over 32 years.
Registered with ROC Delhi under CIN U74899DL1994PTC056894.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.88 Cr. Formerly known as Promed Exports Private Limited. It is led by directors including Canakapalli Bhaktavatasala Rao and Deepak Bahri.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,262.74 Cr, a growth of 43% compared to the previous year.
The company has a workforce of approximately 689 employees as per the latest available data.
The company is associated with 1 brand - Sentiss Pharma. As per MCA filings, the company has open charges of ₹504.85 Cr and satisfied charges of ₹795.76 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sentisspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Sentiss Pharma Private Limited
Sentiss Pharma Private Limited operates one associated brand: Sentiss Pharma. These brands represent Sentiss Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures ophthalmic, inhalational, ENT, and specialty drugs worldwide. | sentisspharma.com |
Competitors & Alternatives of Sentiss Pharma Private Limited
Brands and companies operating in the same space as Sentiss Pharma Private Limited include Annexon, Decibel Therapeutics, Alimera Sciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Developer of antibodies to treat complement-mediated neurodegenerative diseases | San Francisco, United States, United States | 2011 |
|
|
Medicines are developed to protect, repair, and restore hearing capacity. | Cambridge, United States, United States | 2015 |
|
|
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | Alpharetta, United States, United States | 2003 |
|
|
Small molecule therapeutics for ENT diseases are developed. | Watertown, United States, United States | 2005 |
|
|
Gene therapies for ocular and neurodegenerative diseases are developed. | New York, United States, United States | 2015 |
|
|
Drug candidates for immune-mediated diseases are developed by Aldeyra. | Lexington, United States, United States | 2004 |
|
|
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed. | Valbonne, France, France | 1996 |
|
|
Viral vector-based gene therapies for retinal diseases are developed. | Paris, France, France | 2011 |
|
|
Developer of therapeutic solutions for the treatment of diabetes | Redwood City, United States, United States | 2012 |
|
|
Mobile SDK developed for app engagement and monetization strategies. | San Francisco, United States, United States | 2016 |
Business Activity of Sentiss Pharma Private Limited
Sentiss Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Sentiss Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Sentiss Pharma Private Limited
Sentiss Pharma Private Limited is audited by S.R. Batliboi & CO. LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.R. Batliboi & CO. LLP | Locked | Locked | Locked |
Complete auditor history for Sentiss Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sentiss Pharma Private Limited
Sentiss Pharma Private Limited is currently managed by 6 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Canakapalli Bhaktavatasala Rao | Director | 29 Apr 2019 | 7 Years 3 Months | Current |
|
Deepak Bahri
Also directs:
Rubicon Securities Private Limited, Pulse Pharma Private Limited
|
Managing Director | 01 May 1995 | 31 Years 3 Months | Current |
| Mahesh Kumar Garg | Director | 09 Jun 2015 | 11 Years 2 Months | Current |
|
Geeta Mathur
Also directs:
Healthcare Global Enterprises Limited, Dixon Technologies (India) Limited, Ashok Leyland Limited and 5 more
|
Director | 17 Jul 2017 | 9 Years 0 Months | Current |
| Sameer Agarwal | Director | 10 Feb 2025 | 1 Years 6 Months | Current |
| Deepak Kumar Khungar | Director | 21 Nov 2024 | 1 Years 8 Months | Current |
Financials of Sentiss Pharma Private Limited FY 2025 filings available
Sentiss Pharma Private Limited reported revenue of ₹1,262.74 Cr (up 43.00% YoY) for FY 2025.
Ten-year financial statements for Sentiss Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sentiss Pharma Private Limited
Shareholding and ownership data for Sentiss Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sentiss Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2025 | Yes Bank Limited | ₹230.97 Cr | Open |
| 15 Mar 2025 | Others | ₹20 Cr | Open |
| 26 Nov 2024 | Others | ₹54.88 Cr | Open |
| 28 Feb 2024 | Hdfc Bank Limited | ₹30 Cr | Open |
| 23 Sep 2023 | Others | ₹50 Cr | Open |
Total charge records: 33 View all charges
Employees and EPFO Compliance at Sentiss Pharma Private Limited
Sentiss Pharma Private Limited has a workforce of 689 employees as of Apr 06, 2024.
Employee and EPFO history for Sentiss Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Sentiss Pharma Private Limited
GST registrations and filing compliance for Sentiss Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Sentiss Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Sentiss Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sentiss Pharma Private Limited
MSME payment history for Sentiss Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sentiss Pharma Private Limited
Corporate group structure for Sentiss Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sentiss Pharma Private Limited
MCA filings and documents for Sentiss Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Sentiss Pharma Private Limited
Frequently Asked Questions about Sentiss Pharma Private Limited
Sentiss Pharma Private Limited is an active private limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 13 January 1994 (32+ years old) and is registered under CIN U74899DL1994PTC056894. The company has 689 employees.
Sentiss Pharma Private Limited reported revenue of ₹1,262.74 Cr for FY 2025 (up 43.00% YoY).
The current directors of Sentiss Pharma Private Limited are:
- Canakapalli Bhaktavatasala Rao - Director
- Deepak Bahri - Managing Director
- Mahesh Kumar Garg - Director
- Geeta Mathur - Director
- Sameer Agarwal - Director
- Deepak Kumar Khungar - Director
The primary industry of Sentiss Pharma Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Sentiss Pharma Private Limited can be reached at the registered office: 212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016, or through the website sentisspharma.com.
The authorised capital is ₹10 Cr, and the paid-up capital is ₹5.88 Cr.